Literature DB >> 11309216

The exploding head syndrome.

M W Green1.   

Abstract

This article reviews the features of an uncommon malady termed "the exploding head syndrome." Sufferers describe terrorizing attacks of a painless explosion within their head. Attacks tend to occur at the onset of sleep. The etiology of attacks is unknown, although they are considered to be benign. Treatment with clomipramine has been suggested, although most sufferers require only reassurance that the spells are benign in nature.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309216     DOI: 10.1007/s11916-001-0043-9

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  7 in total

1.  [The exploding head syndrome].

Authors:  K M Bongers; J P ter Bruggen; C L Franke
Journal:  Ned Tijdschr Geneeskd       Date:  1991-04-06

2.  The exploding head syndrome: polysomnographic recordings and therapeutic suggestions.

Authors:  C Sachs; E Svanborg
Journal:  Sleep       Date:  1991-06       Impact factor: 5.849

3.  Clinical features of the exploding head syndrome.

Authors:  J M Pearce
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

4.  Cephalgia fugax: a momentary headache.

Authors:  L O'Donnell; E A Martin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08

5.  Exploding head syndrome.

Authors:  J M Pearce
Journal:  Lancet       Date:  1988-07-30       Impact factor: 79.321

6.  Violent visual hallucinations and aggression in frontal lobe dysfunction: clinical manifestations of deep orbitofrontal foci.

Authors:  L Fornazzari; K Farcnik; I Smith; G A Heasman; M Ichise
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

Review 7.  The parasomnias.

Authors:  J D Parkes
Journal:  Lancet       Date:  1986-11-01       Impact factor: 79.321

  7 in total
  1 in total

1.  Sleep-related headache and its management.

Authors:  Niranjan N Singh; Pradeep Sahota
Journal:  Curr Treat Options Neurol       Date:  2013-12       Impact factor: 3.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.